发明名称 |
Use of proteases for gluten intolerance |
摘要 |
The present technology relates to an enzyme composition. The enzyme composition may be used to treat gluten intolerant subjects, including suffering from non-Celiac gluten intolerance and/or non-Celiac gluten sensitivity. The enzyme composition may also be used to reduce gluten exposure in certain individuals. For example, the enzyme composition may also be used as a prophylactic to reduce exposure to gluten oligopeptides. |
申请公布号 |
US9498520(B2) |
申请公布日期 |
2016.11.22 |
申请号 |
US201514593203 |
申请日期 |
2015.01.09 |
申请人 |
AMANO ENZYME INC.;AMANO ENZYME USA CO. LTD. |
发明人 |
Jolly James F.;Ido Horoki;Matsubara Hirotaka;Takahashi Tetsuya;Nishio Kyoichi |
分类号 |
A61K38/48;A61K38/17;A61K38/22;A61K38/24;A61K38/43 |
主分类号 |
A61K38/48 |
代理机构 |
McAndrews, Held & Malloy, Ltd. |
代理人 |
McAndrews, Held & Malloy, Ltd. |
主权项 |
1. A method of treating gluten intolerance or reducing gluten exposure in a human subject comprising:
orally administering the subject with a therapeutically effective amount of an enzyme cocktail comprising a gluten degrading enzyme preparation isolated from Aspergillus oryzae with specificity for peptide substrate leucyl-glycyl-glycine (GDEP-LGG), papain, a semi-alkali protease and an enzyme preparation from Penicillium citrinum, wherein the enzyme cocktail degrades a gluten oligopeptide of SEQ ID NO:1 into peptide fragments of four amino acids or less at acidic conditions, and wherein the GDEP-LGG and papain are in a percent relative activity ratio of 80:20 to 20:80. |
地址 |
Nagoya JP |